854 related articles for article (PubMed ID: 19590022)
1. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.
Meisel C; Schefold JC; Pschowski R; Baumann T; Hetzger K; Gregor J; Weber-Carstens S; Hasper D; Keh D; Zuckermann H; Reinke P; Volk HD
Am J Respir Crit Care Med; 2009 Oct; 180(7):640-8. PubMed ID: 19590022
[TBL] [Abstract][Full Text] [Related]
2. Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial.
Spies C; Luetz A; Lachmann G; Renius M; von Haefen C; Wernecke KD; Bahra M; Schiemann A; Paupers M; Meisel C
PLoS One; 2015; 10(12):e0144003. PubMed ID: 26641243
[TBL] [Abstract][Full Text] [Related]
3. Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma.
Flohé S; Lendemans S; Selbach C; Waydhas C; Ackermann M; Schade FU; Kreuzfelder E
Crit Care Med; 2003 Oct; 31(10):2462-9. PubMed ID: 14530752
[TBL] [Abstract][Full Text] [Related]
4. Down-modulation of granulocyte macrophage-colony stimulating factor receptor on monocytes during human septic shock.
Pangault C; Le Tulzo Y; Tattevin P; Guilloux V; Bescher N; Drénou B
Crit Care Med; 2006 Apr; 34(4):1193-201. PubMed ID: 16484916
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock.
Stephens DP; Thomas JH; Higgins A; Bailey M; Anstey NM; Currie BJ; Cheng AC
Crit Care Med; 2008 Feb; 36(2):448-54. PubMed ID: 18216600
[TBL] [Abstract][Full Text] [Related]
6.
Lachmann G; Kurth J; von Haefen C; Yuerek F; Wernecke KD; Spies C
Int J Med Sci; 2017; 14(4):367-375. PubMed ID: 28553169
[No Abstract] [Full Text] [Related]
7. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
[TBL] [Abstract][Full Text] [Related]
8. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.
Presneill JJ; Waring PM; Layton JE; Maher DW; Cebon J; Harley NS; Wilson JW; Cade JF
Crit Care Med; 2000 Jul; 28(7):2344-54. PubMed ID: 10921563
[TBL] [Abstract][Full Text] [Related]
9. Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction.
Lukaszewicz AC; Grienay M; Resche-Rigon M; Pirracchio R; Faivre V; Boval B; Payen D
Crit Care Med; 2009 Oct; 37(10):2746-52. PubMed ID: 19707128
[TBL] [Abstract][Full Text] [Related]
10. Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients.
Rosenbloom AJ; Linden PK; Dorrance A; Penkosky N; Cohen-Melamed MH; Pinsky MR
Chest; 2005 Jun; 127(6):2139-50. PubMed ID: 15947332
[TBL] [Abstract][Full Text] [Related]
11. A novel biomarker-guided immunomodulatory approach for the therapy of sepsis.
Trapnell BC
Am J Respir Crit Care Med; 2009 Oct; 180(7):585-6. PubMed ID: 19762591
[No Abstract] [Full Text] [Related]
12. Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock.
Schefold JC; Zeden JP; Pschowski R; Hammoud B; Fotopoulou C; Hasper D; Fusch G; Von Haehling S; Volk HD; Meisel C; Schütt C; Reinke P
Scand J Infect Dis; 2010 Mar; 42(3):164-71. PubMed ID: 19958238
[TBL] [Abstract][Full Text] [Related]
13. Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal sepsis: a randomized, double-blind, placebo-controlled clinical trial.
Orozco H; Arch J; Medina-Franco H; Pantoja JP; González QH; Vilatoba M; Hinojosa C; Vargas-Vorackova F; Sifuentes-Osornio J
Arch Surg; 2006 Feb; 141(2):150-3; discussion 154. PubMed ID: 16490891
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores decreased monocyte HLA-DR expression after cardiopulmonary bypass.
Börgermann J; Friedrich I; Scheubel R; Kuss O; Lendemans S; Silber RE; Kreuzfelder E; Flohé S
Thorac Cardiovasc Surg; 2007 Feb; 55(1):24-31. PubMed ID: 17285470
[TBL] [Abstract][Full Text] [Related]
15. A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction.
Presneill JJ; Harris T; Stewart AG; Cade JF; Wilson JW
Am J Respir Crit Care Med; 2002 Jul; 166(2):138-43. PubMed ID: 12119223
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.
Stone RM; Berg DT; George SL; Dodge RK; Paciucci PA; Schulman P; Lee EJ; Moore JO; Powell BL; Schiffer CA
N Engl J Med; 1995 Jun; 332(25):1671-7. PubMed ID: 7760868
[TBL] [Abstract][Full Text] [Related]
17. Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study.
Leentjens J; Kox M; Koch RM; Preijers F; Joosten LA; van der Hoeven JG; Netea MG; Pickkers P
Am J Respir Crit Care Med; 2012 Nov; 186(9):838-45. PubMed ID: 22822024
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis.
Bo L; Wang F; Zhu J; Li J; Deng X
Crit Care; 2011; 15(1):R58. PubMed ID: 21310070
[TBL] [Abstract][Full Text] [Related]
19. Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: a double-blind randomized placebo controlled trial.
Boerma EC; Koopmans M; Konijn A; Kaiferova K; Bakker AJ; van Roon EN; Buter H; Bruins N; Egbers PH; Gerritsen RT; Koetsier PM; Kingma WP; Kuiper MA; Ince C
Crit Care Med; 2010 Jan; 38(1):93-100. PubMed ID: 19730258
[TBL] [Abstract][Full Text] [Related]
20. GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation.
Greenberg P; Advani R; Keating A; Gulati SC; Nimer S; Champlin R; Karanes C; Gorin NC; Powles RL; Smith A; Lamborn K; Cuffie C
Bone Marrow Transplant; 1996 Dec; 18(6):1057-64. PubMed ID: 8971373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
